Page last updated: 2024-08-23

staurosporine and Hodgkin Disease

staurosporine has been researched along with Hodgkin Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holtick, U; Horn, F; Kube, D; Kussebi, N; Lauber, K; Löffler, D; Pinkert, D; Schoof, N; Stürzenhofecker, B; Trümper, L; Vockerodt, M; Wesselborg, S1
Jürgensmeier, JM; Kashkar, H; Krönke, M1

Other Studies

2 other study(ies) available for staurosporine and Hodgkin Disease

ArticleYear
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.
    Leukemia, 2005, Volume: 19, Issue:6

    Topics: Apoptosis; Cell Division; DNA-Binding Proteins; Enzyme Inhibitors; fas Receptor; Gene Expression; Hodgkin Disease; Humans; Jurkat Cells; Nitriles; Phosphorylation; Protein Kinase Inhibitors; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Staurosporine; Trans-Activators; Tyrphostins

2005
Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis.
    Cell death and differentiation, 2002, Volume: 9, Issue:7

    Topics: Apoptosis; B-Lymphocytes; bcl-2-Associated X Protein; Caspase 3; Caspases; Drug Resistance; Enzyme Activation; Enzyme Inhibitors; Hodgkin Disease; Humans; Mitochondria; Protein Kinase C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Staurosporine; Tumor Cells, Cultured

2002